⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2025

Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Zhijun Zhou Yang Cai Hao Yuan Qun Chen Sophia W. Zhao Jingxuan Yang Mingyang Liu Alex X. Arreola Yu Ren Chao Xu Lacey R. McNally Michael S. Bronze Courtney W. Houchen Kuirong Jiang Wei R. Chen Yuqing Zhang Min Li

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: Ferroptosis score correlates with overall survival for cancer patients not treated with immunotherapy.
KEY EVIDENCE: Higher ferroptosis scores were linked to improved survival rates, emphasizing its predictive potential.
APPROACH: The analysis involved evaluating ferroptosis scores in patients and comparing them to survival outcomes.
SIGNIFICANCE: Understanding ferroptosis could offer insights into patient prognosis and guide treatment strategies in cancer care.

Implication

Analysis reveals correlation between ferroptosis score and overall survival in cancer patients, indicating its potential as a biomarker.

Abstract

Supplementary Fig. S3. Correlation between ferroptosis score and overall survival in cancer patients without receiving immunotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d17eb https://doi.org/10.1158/2767-9764.29836660

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
2Supplementary Fig. S4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
3Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
4Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
5Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025

Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025